NEW YORK, NY – VanDeMark Chemical Inc., Lockport, NY, a manufacturer of phosgene and phosgene derivatives, has acquired Framochem Kft, a manufacturer of phosgene products based in Hungary.
The purchase unites two companies with complementary product offerings, having a combined total of 22,000 tons in annual production capacity for phosgene. According to VanDeMark Chemical, the acquisition creates one of the world’s largest independent manufacturers of products based on phosgenation chemistry. These compounds are widely used in the pharmaceutical, agricultural-chemical, personal care, polymer and fine chemical industries.
“Like VanDeMark, Framochem has extensive experience in the implementation of batch and continuous processes both on laboratory and industrial scales,” said György Emri, Managing Director, Framochem. “Having VanDeMark add to our capability in Europe, as well as applying Framochem expertise in North America, will benefit all of our customers in terms of product quality, reliability and delivery.”
Framochem was a subsidiary of ISOCHEM S.A.S., a company of the Munich-based AURELIUS Group. As part of the transaction, VanDeMark has also acquired a sales office in Germany, ISOCHEM Deutschland GmbH.